SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump For President

The TRUMP token is experiencing significant volatility and trading volume as community members debate its legitimacy and connection to political events, including speculation surrounding event invitations and broader geopolitical tensions. Conversations remain highly polarized, with many investors dismissing the asset as a speculative grift while others track its movements as a proxy for the ongoing political climate.

PayPay Corp. engages in the development and provision of electronic payment services that include mobile payment. The company was founded on June 15, 2018 and is headquartered in Tokyo, Japan.

PayPay Corp - ADR - Sponsor

PayPay

PayPay is trending due to high volatility and intense retail debate following its recent debut on the Nasdaq as a major fintech IPO. Community discussion is split between those attracted by the company's strong market share and support from institutional investors, and skeptics who are concerned about potential overvaluation and the risks typical of new market entries.

Lipocine, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of the delivery of drugs using proprietary delivery technology. It offers TLANDO, an oral testosterone replacement therapy. The company was founded on October 13, 2011 and is headquartered in Salt Lake City, UT.

Lipocine Inc

Lipocine is currently trending as investors monitor the company's progress toward a year-end NDA submission for its postpartum depression candidate, LPCN 1154. While the community is actively debating the company's cash position and potential for future partnerships, the low float and anticipation surrounding upcoming data catalysts continue to drive significant speculative interest.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing short-term pressure following reports of delays in its next-generation AI model, Avocado, which has sparked intense debate among community members regarding the company's massive capital expenditure and ability to compete with rivals like Google. While some investors view the current dip as a strategic entry point and remain bullish on the long-term potential of Meta's AI infrastructure, others are expressing frustration over the stock's recent performance and are concerned that the company's heavy AI spending is failing to yield immediate results.

Ambiq Micro, Inc. engages in the provision of ultra-low power semiconductor solutions designed to address the significant power consumption challenges of general purpose and AI computing. It operates through the following geographical segments: China, Taiwan, Singapore, and Rest of the World. The company was founded by Scott Hanson, Dennis Sylvester, and David Blaauw on January 20, 2010 and is headquartered in Austin, TX.

Ambiq Micro Inc.

Ambiq Micro, Inc.

Ambiq Micro is generating significant investor buzz as the community closely monitors potential partnerships with major wearable tech brands and expects leadership to capitalize on its proprietary edge AI semiconductor technology. Market participants are actively discussing the stock's future revenue potential and long-term trajectory while keeping a keen eye on upcoming industry conferences for further strategic updates.

Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. It provides medicines and treatments in various therapeutic areas such as cardiovascular, oncology, dermatology, eye care, gastroenterology, immunology, and women's healthcare. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan, and Hong Kong. The JANZ segment covers operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses operations in developing markets and emerging economies including in Asia, the Middle East, South and Central America, Africa, and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

Viatris Inc

Viatris is gaining momentum as investors pivot toward its robust cash flow and capital return strategy, highlighted by recent earnings that beat top and bottom-line expectations despite a temporary production hurdle. Community sentiment remains mixed between long-term optimism regarding its balance sheet restructuring and caution surrounding historical guidance challenges and sector-wide regulatory pressures.

Murphy Oil Corp. is a holding company, which engages in the exploration and production of oil and natural gas. It operates through the Exploration and Production, and Corporate and Other segments. The Exploration and Production segment includes the United States, Canada, and all other countries. The Corporate and Other segment focuses on interest income, other gains and losses, interest expense, and unallocated overhead. The company was founded by Charles H. Murphy Jr. in 1950 and is headquartered in Houston, TX.

Murphy Oil Corp.

Murphy Oil is trending as investors monitor its long-term resource potential, bolstered by appraisal work in Vietnam and recent analyst upgrades that cite an improved oil price outlook. The community is actively debating the stock's role in the broader energy landscape, with discussions focused on its capital allocation strategy, production growth, and the impact of global supply dynamics on its valuation.

ProShares Trust - ProShares UltraPro Short S&P 500

ProShares UltraPro Short S&P 500 ETF

Investors are actively discussing potential market corrections and hedging strategies as the community debates the impact of geopolitical tensions and economic policies on the S&P 500. Sentiment remains polarized, with many traders utilizing SPXU as a leveraged tool to either profit from anticipated downside or protect their portfolios against perceived overvaluation and increased market volatility.

Voyager Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on December 19, 2023 and is headquartered in Houston, TX.

Voyager Acquisition Corp. - Units (1 Ord Class A & 1/2 War)

Voyager Acquisition Corp. is drawing investor interest following high share redemptions associated with its upcoming merger with VERAXA Biotech. Community members are actively debating the stock's valuation relative to its trust value and the impact of the equity and warrant structure on its price action.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc is seeing intense trading activity driven by a combination of high short interest and anticipation surrounding a potential short squeeze, with the community actively debating whether recent volatility is a setup for a breakout or a temporary pullback. Investors are heavily focused on the stock's growth trajectory and recent business narrative, using technical indicators and social momentum to gauge whether the current price levels offer a strong entry point.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sera Prognostics (NASDAQ:SERA) CEO Zhenya Lindgardt Sells 22,639 Shares

Sera Prognostics, Inc. (NASDAQ:SERA - Get Free Report) CEO Zhenya Lindgardt sold 22,639 shares of the firm's stock in a transaction that occurred on Tuesday, March 10th. The shares were sold at an...

Sera Prognostics (NASDAQ:SERA) CEO Sells $43,014.10 in Stock

Sera Prognostics, Inc. (NASDAQ:SERA - Get Free Report) CEO Zhenya Lindgardt sold 22,639 shares of the stock in a transaction dated Tuesday, March 10th. The shares were sold at an average price of...

Austin Aerts Sells 6,069 Shares of Sera Prognostics (NASDAQ:SERA) Stock

Sera Prognostics, Inc. (NASDAQ:SERA - Get Free Report) CFO Austin Aerts sold 6,069 shares of the business's stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of...

The Joint Corp. (JYNT) Beats Q4 Earnings and Revenue Estimates

The Joint (JYNT) delivered earnings and revenue surprises of +33.33% and +10.59%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Sera Prognostics (SERA) Expected to Announce Quarterly Earnings on Wednesday

Sera Prognostics (NASDAQ:SERA) will be releasing its Q4 2025 earnings after the market closes on Wednesday, March 18. (View Earnings Report at...

LifeMD, Inc. (LFMD) Reports Q4 Loss, Tops Revenue Estimates

LifeMD (LFMD) delivered earnings and revenue surprises of -300.00% and +5.92%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Enhabit (EHAB) Matches Q4 Earnings Estimates

Enhabit (EHAB) delivered earnings and revenue surprises of +3.70% and +0.40%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FOURTH QUARTER AND FISCAL YEAR 2025 FINANCIAL RESULTS ON MARCH 18, 2026

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FOURTH QUARTER AND FISCAL YEAR 2025 FINANCIAL RESULTS ON MARCH 18, 2026 SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FOURTH...

Enhabit (EHAB) Surges 22.6%: Is This an Indication of Further Gains?

Enhabit (EHAB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Sera Prognostics (NASDAQ:SERA) Stock Price Down 2.3% - Here's Why

Sera Prognostics (NASDAQ:SERA) Shares Down 2.3% - Should You Sell...

Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.

SERA
Sera Prognostics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SERA News

SERASera Prognostics Inc